Expression of p53 Protein Associates with Anti-PD-L1 Treatment Response on Human-Derived Xenograft Model of GATA3/CR5/6-Negative Recurrent Nonmuscular Invasive Bladder Urothelial Carcinoma

Background: The possible involvement of p53 signaling, FGFR3 expression, and FGFR3 mutation rates in the prediction of the NMIBC anti-PD-L1 treatment response needs to be clarified. The main aim of our study was to explore predictive value of p53 expression, FGFR3 expression, and its gene mutation s...

Descripción completa

Detalles Bibliográficos
Autores principales: Blinova, Ekaterina, Samishina, Elena, Deryabina, Olga, Blinov, Dmitry, Roshchin, Dmitry, Shich, Evgeniia, Tumutolova, Oxana, Fedoseykin, Ilya, Epishkina, Anna, Barakat, Haydar, Kaprin, Andrey, Zhandarov, Kirill, Perepechin, Dmitrij, Merinov, Dmitrij, Brykin, Gordey, Arutiunian, Karen, Serebrianyi, Stanislav, Mirontsev, Artem, Kozdoba, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465184/
https://www.ncbi.nlm.nih.gov/pubmed/34576020
http://dx.doi.org/10.3390/ijms22189856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465184/
https://www.ncbi.nlm.nih.gov/pubmed/34576020
http://dx.doi.org/10.3390/ijms22189856

Ejemplares similares